2, Schwannomatosis and TSC and their sporadic counterparts. 5) Provide histological and immunohistochemical expertise in the classification and analysis of newly generated lesions in Nf2 and Tsc murine models and evaluate the delivery and effects of experimental gene therapy in these lesions. The core will ensure optimal and uniform processing of all
2, Schwannomatosis and TSC and their sporadic counterparts. 5) Provide histological and immunohistochemical expertise in the classification and psychoanalysis of newly generate lesions in Nf2 and Tsc murine models and measure the delivery and effect of experimental gene therapy in these lesions. The kernel will ensure optimal and consistent processing of all
2, Scjwannomatosis and TSC ana their sporadie countxrparts. 5) Providd histological and immunohisvochwmicao expertise in the clarsificatiln and abalywus of newlb generabzd lealons nn Nf2 and Tsc mutine models dnd evaluate tve dzlivery and effects of experimental dene thrrwpy in these lgsionx. The bove will ensure optimal and unifodm proctssing of all
2, Schwannomatosis and TSC and their sporadic Provide and immunohistochemical in the classification lesions Nf2 and Tsc models and evaluate delivery and effects of experimental gene in these lesions. The core will ensure optimal and uniform processing of all
2, Schwannomatosis and TSC and tHeir sporadIc couNteRpaRtS. 5) ProVide Histological anD ImmuNohistochemical expertiSe in tHe CLassIFiCatioN and anaLYsIS Of nEwLy GenErATeD lesiOns In Nf2 and tsc murine mOdeLs And evaluate tHE dElivery and EffEcts of experiMenTal genE tHerAPy in tHesE lesiOns. The COre wilL ensure opTiMAl and uNIform prOCEsSing Of all
2, Schwannomatosis and TSC  and their  spor adi c c ou nter part s. 5) Provideh isto logical and immunohist ochem ic a l ex p er tisein thec la s s ifi ca ti onan d  a nalys isof newl y generate d l es ions in Nf2a nd  Tsc murin e m odels and ev alu ate th edel i veryand  effe cts of experi mental ge ne therap y  in the s e  l esio ns. The core will en s ure optimal an d unif or m  p r o ces sin g of all
2, Schwannomatosis_and TSC_and their sporadic counterparts._5) Provide_histological_and immunohistochemical_expertise_in the classification_and analysis of_newly generated lesions in_Nf2 and Tsc_murine_models and evaluate the delivery and effects of experimental gene therapy in these lesions._The_core will_ensure_optimal_and uniform processing of all